Moderna Vaccine ‘Hits the Mark’ as Street Sees a Blockbuster

(Bloomberg) -- Moderna Inc. got a new Wall Street-high price target from Goldman Sachs as its shares traded at a record after the biotech company revealed positive early results from its experiment...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.